| 1 |
Past, Present, and Future Perspectives of Transcription Factor EB (TFEB): Mechanisms of regulation and association in disease |
2022 |
| 2 |
Regulation of Hippo signaling by metabolic pathways in cancer |
2022 |
| 3 |
Hypermethylation of Mest promoter causes aberrant Wnt signaling in the patients of Alzheimer’s disease |
2021 |
| 4 |
Regulation of the low-density lipoprotein receptor-related protein LRP6 and its association with disease: Wnt/β-catenin signaling and beyond |
2021 |
| 5 |
Role of the Hippo pathway and mechanisms for controlling cellular localization of YAP/TAZ |
2021 |
| 6 |
PARsylated transcription factor EB (TFEB) regulates the expression of a subset of Wnt target genes by forming a complex with β-catenin-TCF/LEF1 |
2021 |
| 7 |
TFEB Regulates Pluripotency Transcriptional Network in Mouse Embryonic Stem Cells Independent of Autophagy-lysosomal Biogenesis |
2021 |
| 8 |
LGK974 suppresses lipopolysaccharide-induced endotoxemia in mice by modulating the crosstalk between the Wnt/β-catenin and NF-κB pathways |
2021 |
| 9 |
LDL receptor-related protein LRP6 senses the level of nutrient and regulates Hippo signaling. |
2020 |
| 10 |
MAML1/2 promote YAP/TAZ nuclear localization to enhance tumorigenesis |
2020 |
